• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Design and synthesis of novel 8-(azaindolyl)-benzoazepinones as potent and selective ROCK inhibitors.新型8-(氮杂吲哚基)-苯并氮杂䓬酮作为强效和选择性ROCK抑制剂的设计与合成
RSC Med Chem. 2024 Sep 16;15(11):3862-79. doi: 10.1039/d4md00313f.
2
Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.新型咪唑取代二肽酰胺的设计与合成:作为白色念珠菌肉豆蔻酰辅酶A:蛋白质N-肉豆蔻酰转移酶的强效和选择性抑制剂以及具有基于机制的抗真菌活性的相关三肽抑制剂的鉴定
J Med Chem. 1997 Aug 1;40(16):2609-25. doi: 10.1021/jm970094w.
3
Structure-Based Virtual Screening and De Novo Design to Identify Submicromolar Inhibitors of G2019S Mutant of Leucine-Rich Repeat Kinase 2.基于结构的虚拟筛选和从头设计鉴定富亮氨酸重复激酶 2 G2019S 突变体的亚毫摩尔抑制剂。
Int J Mol Sci. 2022 Oct 24;23(21):12825. doi: 10.3390/ijms232112825.
4
Design and synthesis of potent and selective azaindole-based Rho kinase (ROCK) inhibitors.强效且选择性的氮杂吲哚基Rho激酶(ROCK)抑制剂的设计与合成。
ChemMedChem. 2008 Dec;3(12):1893-904. doi: 10.1002/cmdc.200800211.
5
ROCK inhibitors 4: Structure-activity relationship studies of 7-azaindole-based rho kinase (ROCK) inhibitors.ROCK 抑制剂 4:基于 7-氮杂吲哚的 rho 激酶(ROCK)抑制剂的结构-活性关系研究。
Bioorg Med Chem Lett. 2021 Feb 1;33:127721. doi: 10.1016/j.bmcl.2020.127721. Epub 2020 Nov 28.
6
Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid.基于苯并异恶唑部分的强效选择性醛酮还原酶1C3(AKR1C3)抑制剂:生物电子等排体骨架跃迁方法在氟芬那酸中的应用
Eur J Med Chem. 2018 Apr 25;150:930-945. doi: 10.1016/j.ejmech.2018.03.040. Epub 2018 Mar 16.
7
Identification of Selective Dual ROCK1 and ROCK2 Inhibitors Using Structure-Based Drug Design.基于结构的药物设计鉴定选择性双重 ROCK1 和 ROCK2 抑制剂。
J Med Chem. 2018 Dec 27;61(24):11074-11100. doi: 10.1021/acs.jmedchem.8b01098. Epub 2018 Dec 12.
8
Linking phenotype to kinase: identification of a novel benzoxaborole hinge-binding motif for kinase inhibition and development of high-potency rho kinase inhibitors.将表型与激酶联系起来:鉴定新型苯并恶硼烷铰链结合基序以抑制激酶并开发高活性 rho 激酶抑制剂。
J Pharmacol Exp Ther. 2013 Dec;347(3):615-25. doi: 10.1124/jpet.113.207662. Epub 2013 Sep 18.
9
ROCK inhibitors 3: Design, synthesis and structure-activity relationships of 7-azaindole-based Rho kinase (ROCK) inhibitors.ROCK抑制剂3:基于7-氮杂吲哚的Rho激酶(ROCK)抑制剂的设计、合成及构效关系
Bioorg Med Chem Lett. 2018 Aug 15;28(15):2622-2626. doi: 10.1016/j.bmcl.2018.06.040. Epub 2018 Jun 19.
10
Discovery of potent and selective PI3Kδ inhibitors bearing amino acid fragments.携带氨基酸片段的强效且选择性PI3Kδ抑制剂的发现。
Bioorg Chem. 2023 Sep;138:106594. doi: 10.1016/j.bioorg.2023.106594. Epub 2023 May 8.

引用本文的文献

1
KinasePred: A Computational Tool for Small-Molecule Kinase Target Prediction.激酶预测:一种用于小分子激酶靶点预测的计算工具。
Int J Mol Sci. 2025 Feb 27;26(5):2157. doi: 10.3390/ijms26052157.

本文引用的文献

1
Discovery of 3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one derivatives as a new class of ROCK inhibitors for the treatment of glaucoma.发现 3,4-二氢苯并[f][1,4]恶嗪-5(2H)-酮衍生物作为一种新型 ROCK 抑制剂用于治疗青光眼。
Bioorg Med Chem Lett. 2021 Aug 1;45:128138. doi: 10.1016/j.bmcl.2021.128138. Epub 2021 May 24.
2
Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature.Rho激酶抑制剂在眼科中的应用:文献综述
Med Hypothesis Discov Innov Ophthalmol. 2018 Fall;7(3):101-111.
3
Identification of Selective Dual ROCK1 and ROCK2 Inhibitors Using Structure-Based Drug Design.基于结构的药物设计鉴定选择性双重 ROCK1 和 ROCK2 抑制剂。
J Med Chem. 2018 Dec 27;61(24):11074-11100. doi: 10.1021/acs.jmedchem.8b01098. Epub 2018 Dec 12.
4
ROCK inhibitors 3: Design, synthesis and structure-activity relationships of 7-azaindole-based Rho kinase (ROCK) inhibitors.ROCK抑制剂3:基于7-氮杂吲哚的Rho激酶(ROCK)抑制剂的设计、合成及构效关系
Bioorg Med Chem Lett. 2018 Aug 15;28(15):2622-2626. doi: 10.1016/j.bmcl.2018.06.040. Epub 2018 Jun 19.
5
ROCK inhibitors 2. Improving potency, selectivity and solubility through the application of rationally designed solubilizing groups.ROCK抑制剂2. 通过应用合理设计的增溶基团提高效力、选择性和溶解度。
Bioorg Med Chem Lett. 2018 Aug 15;28(15):2616-2621. doi: 10.1016/j.bmcl.2018.06.043. Epub 2018 Jun 21.
6
ROCK inhibition in models of neurodegeneration and its potential for clinical translation.神经退行性疾病模型中的 ROCK 抑制及其临床转化的潜力。
Pharmacol Ther. 2018 Sep;189:1-21. doi: 10.1016/j.pharmthera.2018.03.008. Epub 2018 Apr 3.
7
Design of Aminobenzothiazole Inhibitors of Rho Kinases 1 and 2 by Using Protein Kinase A as a Structure Surrogate.设计蛋白激酶 A 为结构替代物的 Rho 激酶 1 和 2 的氨苯并噻唑抑制剂。
Chembiochem. 2018 Mar 16;19(6):613-621. doi: 10.1002/cbic.201700547. Epub 2018 Jan 30.
8
Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10.前沿:选择性口服ROCK2抑制剂可降低寻常型银屑病患者的临床评分,并通过同时调节IL-17和IL-10使皮肤病理学恢复正常。
J Immunol. 2017 May 15;198(10):3809-3814. doi: 10.4049/jimmunol.1602142. Epub 2017 Apr 7.
9
Y-27632, a Rho-Associated Protein Kinase Inhibitor, Inhibits Voltage-Dependent K+ Channels in Rabbit Coronary Arterial Smooth Muscle Cells.Y-27632,一种Rho相关蛋白激酶抑制剂,可抑制兔冠状动脉平滑肌细胞中的电压依赖性钾通道。
Pharmacology. 2016;98(5-6):220-227. doi: 10.1159/000447745. Epub 2016 Jul 21.
10
Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain.Rho相关蛋白激酶1(ROCK1)在阿尔茨海默病中表达增加,而敲低ROCK1可降低大脑中的β淀粉样蛋白水平。
J Neurochem. 2016 Aug;138(4):525-31. doi: 10.1111/jnc.13688. Epub 2016 Jul 1.

新型8-(氮杂吲哚基)-苯并氮杂䓬酮作为强效和选择性ROCK抑制剂的设计与合成

Design and synthesis of novel 8-(azaindolyl)-benzoazepinones as potent and selective ROCK inhibitors.

作者信息

Pala Daniele, Clark David, Edwards Christine, Pasqua Elisa, Tigli Laura, Pioselli Barbara, Malysa Piotr, Facchinetti Fabrizio, Rancati Fabio, Accetta Alessandro

机构信息

Global Research and Preclinical Development, Chiesi Farmaceutici S.p.A Parma 43122 Italy

Charles River Laboratories 8-9 Spire Green Centre Harlow CM19 5TR UK.

出版信息

RSC Med Chem. 2024 Sep 16;15(11):3862-79. doi: 10.1039/d4md00313f.

DOI:10.1039/d4md00313f
PMID:39297059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11406669/
Abstract

We report the characterization of potent and selective ROCK inhibitors identified through a core-hopping strategy. A virtual screening workflow, combining ligand- and structure-based methods, was applied on a known series of ROCK inhibitors bearing an acetamido-thiazole scaffold. The most promising replacement of the central core was represented by a benzoazepinone ring, which was selected as a starting point for a subsequent chemical exploration. The overall design approach exploited previous SARs available for congeneric series and crystallographic information to optimize the hinge-binding group as well as the terminal aromatic moiety interacting with the glycine-rich loop. The introduction of elongated and flexible charged groups led to compound 15, which exhibited sub-nanomolar potencies in biochemical and cellular assays, as well as a remarkable selectivity over PKA. HDX studies not only supported the postulated binding mode of compound 15 but also confirmed the crucial role of specific ROCK peptide segments in driving ligand selectivity.

摘要

我们报告了通过核心跳跃策略鉴定出的强效且选择性的ROCK抑制剂的特征。一种结合基于配体和基于结构方法的虚拟筛选工作流程,应用于一系列已知的带有乙酰氨基噻唑支架的ROCK抑制剂。最有前景的核心替换物是苯并氮杂卓酮环,它被选作后续化学探索的起点。整体设计方法利用了同类系列可用的先前构效关系和晶体学信息,以优化铰链结合基团以及与富含甘氨酸环相互作用的末端芳香部分。引入细长且灵活的带电基团得到了化合物15,它在生化和细胞测定中表现出亚纳摩尔级的效力,以及对PKA的显著选择性。氢氘交换研究不仅支持了化合物15假定的结合模式,还证实了特定ROCK肽段在驱动配体选择性方面的关键作用。